亚洲精品1234,久久久久亚洲国产,最新久久免费视频,我要看一级黄,久久久性色精品国产免费观看,中文字幕久久一区二区三区,久草中文网

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Australian man hospitalized with blood clots after Pfizer jab

Xinhua | Updated: 2021-04-21 14:50
Share
Share - WeChat
A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. [Photo/Agencies]

SYDNEY -- A policeman was reportedly being treated for blood clots on Wednesday in the Australian state of Queensland after receiving the Pfizer COVID-19 vaccine on Sunday.

The man, aged 40, had been patrolling the state's COVID-19 quarantine hotels. He was rushed to hospital in the state capital of Brisbane after developing the clots.

Health authorities are reportedly on high alert and an investigation has been launched. At this stage no formal statement has been made.

Deputy Premier Steven Miles said on Wednesday that it was too early to say if the incident was linked to the Pfizer vaccine.

"What people should be very confident in, though, is that our medical authorities are determined to investigate any such incident and provide that information and data, nationally and indeed internationally," Miles said.

At least 14 people in Australia are known to have had allergic reactions to the Pfizer vaccine, but none had developed blood clots.

According to the World Health Organization, typical side effects of COVID-19 vaccines can include pain at the jab site, fever, fatigue, headache, muscle pain, chills and diarrhoea.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US